镇肝熄风汤联合替罗非班治疗进展性脑梗死临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.3

基金项目:

开封市科技发展资助项目(2003065)


Clinical Study on Zhen'gan Xifeng Tang Combined with Tirofiban for Progressive Cerebral Infarction
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察镇肝熄风汤联合替罗非班治疗进展性脑梗死的临床疗效。方法:将 90 例进展性脑梗死患者按随机数字表法分为观察组与对照组各 45 例。2 组均给予抗血小板聚集、营养脑细胞、降脂稳定斑块、清除自由基等基础治疗,对照组在此基础上加用替罗非班注射液治疗,观察组在对照组基础上联合镇肝熄风汤治疗,2 组均治疗 14 d。比较 2 组临床疗效,观察 2 组治疗前后中医证候积分、美国国立卫生研究院卒中量表 (NIHSS) 评分、改良 Rankin 量表 (mRS) 评分、超敏 C-反应蛋白(hs-CRP)、白细胞介素-6(IL-6)水平、血小板聚集率(PAgT)、血小板膜糖蛋白(CD62p)的变化。结果:观察组总有效率为93.33%,对照组总有效率为 55.55%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组中医证候积分、NIHSS 评分及 mRS评分均较治疗前降低 (P<0.05),观察组中医证候积分、NIHSS 评分及 mRS 评分均比对照组降低更明显 (P<0.05)。治疗后, 2 组 hs-CRP、IL-6 水平及 PAgT、CD62p 均较治疗前降低 (P<0.05),观察组 hs-CRP、IL-6 水平及 PAgT、CD62p 均较对照组降低更明显(P<0.05)。结论:镇肝熄风汤联合替罗非班治疗进展性脑梗死,可有效改善患者的临床症状,抑制炎症因子释放,减少血小板聚集。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Zhen'gan Xifeng tang combined with tirofiban for progressive cerebral infarction. Methods: A total of 90 cases of patients with progressive cerebral infarction were divided into the observation group and the control group according to the random number table method,45 cases in each group. Both groups were given basic treatments such as anti- platelet aggregation,nourishing brain cells,lipid- lowering and stable plaques, and scavenging free radicals;the control group was additionally treated with tirofiban injection,and the observation group was additionally treated with Zhen'gan Xifeng tang based on the treatment of the control group. Both groups were treated for 14 days. The clinical effect in the two groups was compared; before and after treatment, the changes in the scores of Chinese medicine syndromes,National Institute of Health Stroke Scale(NIHSS),modified Rankin Scale(mRS),hypersensitive C- reactive protein(hs- CRP), interleukin- 6(IL- 6), platelet aggregation rate(PAgT), and platelet membrane glycoprotein (CD62p) in the two groups were observed. Results:The total effective rate was 93.33% in the observation group and 55.55% in the control group,the difference being significant(P<0.05). After treatment,the scores of Chinese medicine syndromes, NHISS and mRS in the two groups were decreased when compared with those before treatment(P<0.05),and the decrease in the observation group was more significant than that in the control group(P<0.05). After treatment,the levels of hs-CRP and IL-6 as well as PAgT and CD62p in the two groups were decreased when compared with those before treatment(P< 0.05),and the decrease in the observation group was more significant than that in the control group(P<0.05). Conclusion: The therapy of Zhen'gan Xifeng tang combined with tirofiban for progressive cerebral infarction can effectively improve the clinical symptoms,inhibit the release of inflammatory factors and reduce the platelet aggregation.

    参考文献
    相似文献
    引证文献
引用本文

王文艳,王松龄,王丽萍.镇肝熄风汤联合替罗非班治疗进展性脑梗死临床研究[J].新中医,2020,52(24):41-44

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-12-22
  • 出版日期:
文章二维码